Yin et al. reported that LPS can remodel the tumour microenvironment and promote the anti-tumour effect via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer [57]. This evidence concerns the gene AKT1 and familial pancreatic carcinoma.